Continuous Renal Replacement Therapy Market
Market Insights on Continuous Renal Replacement Therapy covering sales outlook, demand forecast & up-to-date key trends
Continuous Renal Replacement Therapy Market By types, End Users, Region & Forecast 2017 to 2027
Continuous Renal Replacement Therapy Market Overview
[198 Pages Report] The continuous renal replacement therapy market is valued at US$ 1 Billion in 2021. The market is likely to grow at a CAGR of 7.7% through 2027, reaching US$ 1.68 Billion.
|
Attribute |
Details |
|
Estimated Market Size of Continuous Renal Replacement Therapy Market in 2021 |
US$ 1 Billion |
|
Projected Market Size of Continuous Renal Replacement Therapy Market in 2027 |
US$ 1.68 Billion |
|
CAGR during 2021 to 2027 |
7.7% |
Asia Pacific Excluding Japan is a prominent market reflecting a CAGR of 8.8%, reaching a valuation of US$ 333 Million through 2027.
North America, Western Europe and Asia Pacific Excluding Japan are the lucrative regions of the market collectively accounting for 70% of the global shares.
In 2015, a new regulation 188/15 was introduced under the Excellent Care for All Act that requires hospitals to “engage patients and their caregivers in designing, reviewing and maintaining ... processes for receiving, reviewing and attempting to resolve expeditiously complaints from patients and caregivers.” Baxter Health Care was taking orders on its new Amia PD cycler.
Like other machines manufacturers, Baxter wanted the Amia to be simpler to use, lightweight, and offer technology that connected patients and caregivers. Its Shared Source is a GPS of sorts that helps staff monitor patients while on the cycler.
Let us know your requirement to get
100% FREE customization
Healthcare Services Industry Consolidation
Growth in the number mergers and consolidations between hospitals is expected to have a high impact on the revenue generation of medical device manufacturers. A large number of hospital networks are operating under one organization. These networks can leverage the price of the medical devices with the manufacturers and thereby reduce profit margins. In February 2017, Fresenius Medical Care announced the acquisition of a majority stake in Cura Group (“Cura”), a leading operator of high-quality day hospitals in Australia.
Cura provides a variety of specialised ambulant services, such as ophthalmology and orthopaedic surgeries, in an outpatient setting. Cura was established in 2008 and generated a revenue of AU$127 million (€87 million) in the financial year 2015/2016. This acquisition allows Fresenius Medical Care to further leverage its core competence in operating outpatient facilities, extend its dialysis network and thereby lay the foundation for future growth in the Australian market.
Reformed Healthcare Regulations Challenging Market Growth
Companies are subject to a number of existing laws & regulations and non-compliance, which is likely to adversely affect their business, financial condition and results of operations, and companies are susceptible to a changing regulatory environment. As participants in the healthcare industry, the operations & products of companies as well as customers are regulated by numerous government agencies globally.
The impact of this on the company is direct to the extent that companies are subject to these laws and regulations, as well as indirect in a number of situations. In many instances, the companies may not be directly regulated by specific healthcare laws and regulations, however, their products must be capable of being used by customers in a manner that complies with those laws and regulations.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystShifting Production Base to Emerging Economies
Government and regulatory bodies of various countries are adopting cost-containment measures to reduce the healthcare burden. This shift from volume- to value-based systems is driven by various measures taken by governments, healthcare providers, insurance payers and life sciences companies, which include outcome-based pricing, profit & risk sharing, price control and competitive tendering.
The value-based healthcare system will help achieve the maximum value for money spent on healthcare, and thus improve outcomes through integrated care pathways. At the same time, it will levy pricing pressure on biopharmaceutical and medical device companies and is likely to impact investment in the R&D of innovative medical treatment technologies.
Competitive Landscape
The competition section of the Continuous Renal Replacement Therapy (CRRT) market report features profiles of key players operating in the market based on their market shares, product offerings, differential channel strategies, marketing initiative, product reach and company dashboard.
Some of the key players featured in the report include Fresenius Medical Care AG & Co. KGaA; Baxter International Inc.; B. Braun Melsungen AG; Medica SpA; Nikkiso Co., Ltd.; Nipro corp.; Toray Medical Co., Ltd.; NxStage Medical, Inc.; Asahi Kasei Corp. and Medtronic plc.
Key Players operating in the CRRT market are focused launching novel product lines due to the growing demand from AKI patients. These companies are taking continuous efforts to provide cost-effective CRRT systems in the Asian market. According to WHO, the general availability of kidney dialysis is 60% in countries worldwide.
Its availability is significant in high-income countries and is found to be 93%, whereas its availability in developing and under-developed countries is 46% and 27% respectively. Fresenius Medical Care AG & Co. KGaA, one of the leading providers of dialysis products and services, has launched multi-FiltratePRO, a therapy system for Continuous Renal Replacement Therapy (CRRT), for the treatment of acute kidney failure in critically ill patients at intensive care units.
Some of the key manufacturers of continuous renal replacement therapy are focusing on novel marketing strategies to increase their product reach in the Asian market. Price reduction strategy in consumables will be the critical success factor for leading providers. These companies are receiving fierce competition from local suppliers of consumables. These supplies have a strong hold on conventional distribution channels such as wholesalers and retailers.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Definition
Renal replacement therapy includes dialysis (haemodialysis or peritoneal dialysis, hemofiltration and hemodiafiltration), which is the filtration of blood with or without a machine. CRRT is widely used for acute kidney injury. CRRT is a dialysis modality used to treat critically ill and hospitalised patients in intensive care units who develop Acute Kidney Injury (AKI). Unlike chronic kidney disease, which occurs slowly over time, AKI often occurs in hospitalised patients treated in an intensive care environment, and it typically occurs over a few hours to a few days.
About the Report
Future Market Insights, Inc has conducted a research study on the continuous renal replacement therapy market for the forecast period of 2017 to 2027. The report offers a comprehensive evaluation of the business opportunities prevailing in the continuous renal replacement therapy market along with insights on the consumption trend, market dynamics, disease incidence, reimbursement, patient awareness level, pricing, company penetration and market competition. The report elaborates on the macro-economic factors influencing the dynamics of the continuous renal replacement therapy market and its futuristic potential.
Additional Questions Answered
Some of the additional questions addressed in the report of the continuous renal replacement therapy market are as follows:
- What is role of regulatory authorities and insurance service providers in the market?
- What is the revenue potential of generic continuous renal replacement therapy in the regions of North America and Asia?
- Who are the key competitors and what are their portfolios in the continuous renal replacement therapy market?
- What is the price point for continuous renal replacement therapy manufacturers in developed countries?
For answers to all the possible questions required for gauging the performance of the continuous renal replacement therapy market, get in touch with our expert analysts.
Research Methodology
Future Market Insights, Inc has analysed the size of the continuous renal replacement therapy market by using the triangulation methodology in which we have tracked the revenue of key players operating in this segment. Key players are segmented at a tier-level with respect to their revenues, product portfolio and geographical presence. This process involves the analysis of various company investor presentations, SEC filings, annual reports, earning call transcripts, 10k reports and press releases.
This task is done to fetch substantial information about the key players, their respective revenues and estimate their respective market share. The forecasting of the continuous renal replacement therapy was conducted based on several macro factors such as the per-capita healthcare spending, per-capita pharmaceutical spending, the availability of reimbursements, patient awareness and other macro factors associated with the healthcare industry.
Segmentation
The report offers a comprehensive taxonomy of the continuous renal replacement therapy market based on product type, end user and region. Continuous renal replacement therapy is sold in two types: systems and consumables. The consumables segment covers various types of hemofilter sets, solutions and other accessories.
Increased healthcare spending across emerging economies is expected to encourage the establishment of new multi-specialties in dialysis centres and hospitals, which is, in turn, expected to promote the demand for CRRT. The continuous renal replacement therapy market has been analysed across various regions, which include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa.
Frequently Asked Questions
The continuous renal replacement therapy market is valued at US$ 1 Billion in 2021. The market is likely to grow at a CAGR of 7.7% through 2027, reaching US$ 1.68 Billion.
Some of the key players in the report include Fresenius Medical Care AG & Co. KGaA; Baxter International Inc.; B. Braun Melsungen AG; Medica SpA.
Table of Content
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Analysis Scenario
3.1. Market Volume Analysis
3.1.1. Product Type Volume Analysis By Region
3.2. Pricing Analysis
3.2.1. Pricing Assumptions
3.2.2. Price Projections Per Region
3.3. Market Size (US$ Mn) and Forecast
3.3.1. Market Size and Y-o-Y Growth
3.3.2. Absolute $ Opportunity
3.4. Market Overview
3.4.1. Value Chain
3.4.2. Market Scenario Forecast
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Trends
5. Global Analysis and Forecasts, By Product Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Product Type
5.3. Y-o-Y Growth Projections By Product Type
5.4. Market Value Forecast By Product Type, 2017–2027
5.4.1. Dialysis System
5.4.2. Consumables
5.4.2.1. Hemofilter sets
5.4.2.2. Solution
5.4.2.3. Accessories
5.4.3. Market Attractiveness By Product Type
6. Global Analysis and Forecasts, By End User
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By End User
6.3. Y-o-Y Growth Projections By End User
6.4. Market Value Forecast By End User, 2017–2027
6.4.1. Hospital
6.4.2. Dialysis Center
6.5. Market Attractiveness By End User
7. Global Analysis and Forecasts, By Region
7.1. Basis Point Share (BPS) Analysis By Region
7.2. Y-o-Y Growth Projections By Region
7.3. Market Value Forecast By Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. Asia Pacific Excluding Japan (APEJ)
7.3.6. Japan
7.3.7. Middle East and Africa (MEA)
7.4. Market Attractiveness By Region
8. North America Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Country
8.1.2. Y-o-Y Growth Projections By Country
8.2. Market Value Forecast By Product Type, 2017–2027
8.2.1. Dialysis System
8.2.2. Consumables
8.2.2.1. Hemofilter sets
8.2.2.2. Solution
8.2.2.3. Accessories
8.2.3. Market Value Forecast By End User, 2017–2027
8.2.3.1. Hospital
8.2.3.2. Dialysis Center
8.2.4. Market Value Forecast By Country, 2017–2027
8.2.4.1. S.
8.2.4.2. Canada
8.2.5. Market Attractiveness Analysis
8.2.5.1. By Product Type
8.2.5.2. By End User
8.2.5.3. By Country
9. Latin America Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.2. Market Value Forecast By Product Type, 2017–2027
9.2.1. Dialysis System
9.2.2. Consumables
9.2.2.1. Hemofilter sets
9.2.2.2. Solution
9.2.2.3. Accessories
9.2.3. Market Value Forecast By End User, 2017–2027
9.2.3.1. Hospital
9.2.3.2. Dialysis Center
9.2.4. Market Value Forecast By Country, 2017–2027
9.2.4.1. Brazil
9.2.4.2. Mexico
9.2.4.3. Rest of Latin America
9.2.5. Market Attractiveness Analysis
9.2.5.1. By Product Type
9.2.5.2. By End User
9.2.5.3. By Country
10. Western Europe Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.2. Market Value Forecast By Product Type, 2017–2027
10.2.1. Dialysis System
10.2.2. Consumables
10.2.2.1. Hemofilter sets
10.2.2.2. Solution
10.2.2.3. Accessories
10.2.3. Market Value Forecast By End User, 2017–2027
10.2.3.1. Hospital
10.2.3.2. Dialysis Center
10.2.4. Market Value Forecast By Country, 2017–2027
10.2.4.1. K.
10.2.4.2. France
10.2.4.3. Germany
10.2.4.4. Italy
10.2.4.5. Spain
10.2.4.6. Nordic
10.2.4.7. Benelux
10.2.4.8. Rest of Western Europe
10.2.5. Market Attractiveness Analysis
10.2.5.1. By Product Type
10.2.5.2. By End User
10.2.5.3. By Country
11. Eastern Europe Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2. Market Value Forecast By Product Type, 2017–2027
11.2.1. Dialysis System
11.2.2. Consumables
11.2.2.1. Hemofilter sets
11.2.2.2. Solution
11.2.2.3. Accessories
11.2.3. Market Value Forecast By End User, 2017–2027
11.2.3.1. Hospital
11.2.3.2. Dialysis Center
11.2.4. Market Value Forecast By Country, 2017–2027
11.2.4.1. Russia
11.2.4.2. Poland
11.2.4.3. Rest of Eastern Europe
11.2.5. Market Attractiveness Analysis
11.2.5.1. By Product Type
11.2.5.2. By End User
11.2.5.3. By Country
12. Asia Pacific Excluding Japan (APEJ) Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2. Market Value Forecast By Product Type, 2017–2027
12.2.1. Dialysis System
12.2.2. Consumables
12.2.2.1. Hemofilter sets
12.2.2.2. Solution
12.2.2.3. Accessories
12.2.3. Market Value Forecast By End User, 2017–2027
12.2.3.1. Hospital
12.2.3.2. Dialysis Center
12.2.4. Market Value Forecast By Country, 2017–2027
12.2.4.1. China
12.2.4.2. India
12.2.4.3. Australia & New Zealand
12.2.4.4. ASEAN
12.2.4.5. Rest of APEJ
12.2.5. Market Attractiveness Analysis
12.2.5.1. By Product Type
12.2.5.2. By End User
12.2.5.3. By Country
13. Japan Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.2. Market Value Forecast By Product Type, 2017–2027
13.2.1. Dialysis System
13.2.2. Consumables
13.2.2.1. Hemofilter sets
13.2.2.2. Solution
13.2.2.3. Accessories
13.2.3. Market Value Forecast By End User, 2017–2027
13.2.3.1. Hospital
13.2.3.2. Dialysis Center
13.2.4. Market Attractiveness Analysis
13.2.4.1. By Product Type
13.2.4.2. By End User
14. Middle East and Africa (MEA) Analysis and Forecast
14.1. Introduction
14.1.1. Basis Point Share (BPS) Analysis By Country
14.1.2. Y-o-Y Growth Projections By Country
14.2. Market Value Forecast By Product Type, 2017–2027
14.2.1. Dialysis System
14.2.2. Consumables
14.2.2.1. Hemofilter sets
14.2.2.2. Solution
14.2.2.3. Accessories
14.2.3. Market Value Forecast By End User, 2017–2027
14.2.3.1. Hospital
14.2.3.2. Dialysis Center
14.2.4. Market Value Forecast By Country, 2017–2027
14.2.4.1. GCC Countries
14.2.4.2. South Africa
14.2.4.3. Rest of MEA
14.2.5. Market Attractiveness Analysis
14.2.5.1. By Product Type
14.2.5.2. By End User
14.2.5.3. By Country
15. Competition Landscape
15.1. Competition Dashboard
15.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
15.2.1. Fresenius Medical Care AG & Co. KGaA
15.2.2. Baxter International Inc.
15.2.3. Braun Melsungen AG
15.2.4. Nikkiso Co., Ltd
15.2.5. NxStage Medical, Inc.
15.2.6. Asahi Kasei Corp
15.2.7. NIPRO Corporation
15.2.8. Medica spa.
15.2.9. Toray Medical Co., Ltd,
15.2.10. Medtronic plc.,
15.2.11. Bain Medical Equipment (Guangzhou) Co. Ltd.,
15.2.12. INFOMED SA.,
15.2.13. Medical Components, Inc.,
15.2.14. Medites Pharma, S.R.O.,
15.2.15. Jihua Medical Apparatus & Instruments Co.,
15.2.16. Central Admixture Pharmacy Services Inc.,
15.2.17. Haidylina for Advanced Medical Industries.
15.2.18. Hemoclean Co. Ltd.,
15.2.19. FARMASOL Medical Products Ind. and Trd. Co.,
16. Assumptions and Acronyms Used
17. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Volume (Unit ) Analysis and Forecast By Product Type, 2017-2027
Table 02: Global Market Value (US$ Mn) Analysis and Forecast By Product Type , 2017– 2027
Table 03: Global Market Value (US$ Mn) Analysis and Forecast By End User, 2017–2027
Table 04: Global Market Value (US$ Mn) Analysis and Forecast By Region, 2017–2027
Table 05: North America Market Value (US$ Mn) Analysis and Forecast By Product Type, 2017– 2027
Table 06: North America Market Volume (Unit ) Analysis and Forecast By Product Type, 2017-2027
Table 07: North America Market Value (US$ Mn) Analysis and Forecast By End User, 2017–2027
Table 08: North America Market Value (US$ Mn) Analysis and Forecast By Country, 2017–2027
Table 09: Latin America Market Value (US$ Mn) Analysis and Forecast By Product Type , 2017– 2027
Table 10: Latin America Market Volume (Unit ) Analysis and Forecast By Product Type, 2017-2027
Table 11: Latin America Market Value (US$ Mn) Analysis and Forecast By End User, 2017–2027
Table 12: Latin America Market Value (US$ Mn) Analysis and Forecast By Country, 2017–2027
Table 13: western Europe Market Value (US$ Mn) Analysis and Forecast By Product Type,2017–2027
Table 14: Western Europe Market Volume (Unit ) Analysis and Forecast By Product Type, 2017-2027
Table 15: western Europe Market Value (US$ Mn) Analysis and Forecast By End User, 2017–2027
Table 16: Western Europe Market Value (US$ Mn) Analysis and Forecast By Country, 2017–2027
Table 17: Eastern Europe Market Value (US$ Mn) Analysis and Forecast By Product Type,2017– 2027
Table 18: Eastern Europe Market Volume (Unit ) Analysis and Forecast By Product Type, 2017-2027
Table 19: Eastern Europe Market Value (US$ Mn) Analysis and Forecast By End User, 2017–2027
Table 20: Eastern Europe Market Value (US$ Mn) Analysis and Forecast By Country, 2017–2027
Table 21: APEJ Market Value (US$ Mn) Analysis and Forecast By Product Type , 2017– 2027
Table 22: APEJ Market Volume (Unit ) Analysis and Forecast By Product Type, 2017-2027
Table 23: APEJ Market Value (US$ Mn) Analysis and Forecast By End User, 2017–2027
Table 24: APEJ Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026
Table 25: Japan Market Value (US$ Mn) Analysis and Forecast By Product Type , 2017– 2027
Table 26: Japan Market Volume (Unit ) Analysis and Forecast By Product Type, 2017-2027
Table 27: Japan Market Value (US$ Mn) Analysis and Forecast By End User, 2017–2027
Table 28: MEA Market Value (US$ Mn) Analysis and Forecast By Product Type , 2017– 2027
Table 29: MEA Market Volume (Unit ) Analysis and Forecast By Product Type, 2017-2027
Table 30: MEA Market Value (US$ Mn) Analysis and Forecast By End User, 2017–2027
Table 31: MEA Market Value (US$ Mn) Analysis and Forecast By Country, 2017–2027
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Value (US$ Mn) & Y-o-Y , 2017–2027
Figure 02: Global Continuous Renal Replacement TherapyMarket Absolute $ Opportunity , 2017–2027
Figure 03: Global Market Share Analysis (%) By Product type , 2017 & 2027
Figure 04: Global Market Y-o-Y Growth (%) By Product type, 2017–2027
Figure 05: Global Market Attractiveness Analysis By Product Type, 2017–2027
Figure 06: Global Market Absolute $ Opportunity (US$ Mn) By Dialysis system Segment, 2017– 2027
Figure 07: Global Market Absolute $ Opportunity (US$ Mn) By Consumables Segment, 2017 – 2027
Figure 08: Global Market Share Analysis (%) By End User, 2017 & 2027
Figure 09: Global Market Y-o-Y Growth (%) By End User, 2017–2027
Figure 10: Global Market Attractiveness Analysis By End User, 2017–2027
Figure 11: Global Market Value (US$ Mn) & Y-o-Y , 2017–2027
Figure 12: Global Continuous Renal Replacement TherapyMarket Absolute $ Opportunity , 2017–2027
Figure 13: Global Market Share Analysis (%) By Region, 2017, 2027
Figure 14: Global Market Y-o-Y Growth (%) By Region, 2017–2027
Figure 15: North America Market Absolute $ Opportunity (US$ Mn)Forecast, 2017– 2027
Figure 16: Latin AmericaMarket Absolute $ Opportunity (US$ Mn) By Consumables Segment, 2017 – 2027
Figure 17: Eastern Eur0pe Market Absolute $ Opportunity (US$ Mn) forecast, 2017– 2027
Figure 18: Western Europe Market Absolute $ Opportunity (US$ Mn) Forecast, 2017 – 2027
Figure 19: APEJ Market Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 20: Japan Market Absolute $ Opportunity (US$ Mn) Forecast, 2017 – 2027
Figure 21: MEA Market Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 22: Global Market Attractiveness Analysis By Region, 2017–2027
Figure 23: North America Market Share Analysis (%) By Country, 2017- 2027
Figure 24: North America Market Y-o-Y Growth (%) By Country, 2017–2027
Figure 25: US Market Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 26: Canada Market Absolute $ Opportunity (US$ Mn) Forecast, 2017 – 2027
Figure 27: North America Market Attractiveness Analysis By End User, 2017 – 2027
Figure 28: North America Market Attractiveness Analysis By Product type, 2017 – 2027
Figure 29: North America Market Attractiveness Analysis By Country, 2017 – 2027
Figure 30: Latin America Market Share Analysis (%) By Country, 2017-2027
Figure 31: Latin America Market Y-o-Y Growth (%) By Country, 2017–2027
Figure 32: Brazil Market Absolute $ Opportunity (US$ Mn)Forecast, 2017– 2027
Figure 33: MexicoMarket Absolute $ Opportunity (US$ Mn)Forecast, 2017 – 2027
Figure 34: Rest of Latin America Market Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 35: Latin America Market Attractiveness Analysis By End User, 2017 – 2027
Figure 36: Latin America Market Attractiveness Analysis By Product type, 2017– 2027
Figure 37: Latin America Market Attractiveness Analysis By Country, 2017 – 2027
Figure 38: Western Europe Market Share Analysis (%) By Country, 2017, 2027
Figure 39: Western Europe Market Y-o-Y Growth (%) By Country, 2017–2027
Figure 40: Germany Market Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 41: France Market Absolute $ Opportunity (US$ Mn) Forecast, 2017 – 2027
Figure 42: U.K Market Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 43: Spain Market Absolute $ Opportunity (US$ Mn)Forecast, 2017 – 2027
Figure 44: Italy Market Absolute $ Opportunity (US$ Mn) forecast, 2017– 2027
Figure 45: Nordic Market Absolute $ Opportunity (US$ Mn) Forecast, 2017 – 2027
Figure 46: BENELUX Market Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 47: Rest of Western Europe Market Absolute $ Opportunity (US$ Mn) Forecast, 2017 – 2027
Figure 48: Western Europe Market Attractiveness Analysis By Product Type, 2017-2027
Figure 49: Western Europe Market Attractiveness Analysis By End User, 2017 – 2027
Figure 50: Western Europe market Attractiveness Analysis By country, 2017 – 2027
Figure 51: Eastern Europe Market Share Analysis (%) By Country, 2017, 2027
Figure 52: Eastern Europe Market Y-o-Y Growth (%) By Country, 2017–2027
Figure 53: Russia Market Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 54: Poland Market Absolute $ Opportunity (US$ Mn) Forecast, 2017 – 2027
Figure 55: Rest of Eastern Europe Market Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 56: Eastern Europe Market Attractiveness Analysis By End User , 2017 – 2027
Figure 57: Eastern Europe Market Attractiveness Analysis By Product Type, 2017 – 2027
Figure 58: Eastern Europe Market Attractiveness Analysis By Country , 2017 – 2027
Figure 59: APEJ Market Share Analysis (%) By Country, 2017,2027
Figure 60: APEJ Market Y-o-Y Growth (%) By Country, 2017–2027
Figure 61: ChinaMarket Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 62: India Market Absolute $ Opportunity (US$ Mn) Forecast, 2017 – 2027
Figure 63: ASEAN Market Absolute $ Opportunity (US$ Mn) Forecast , 2017– 2027
Figure 64: A&NZ Market Absolute $ Opportunity (US$ Mn) Forecast, 2017 – 2027
Figure 65: Rest of APEJMarket Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 66: APEJ Market Attractiveness Analysis By End User, 2017 – 2027
Figure 67: APEJ Market Attractiveness Analysis By Product Type, 2017– 2027
Figure 68: APEJ Market Attractiveness Analysis By Country, 2017 – 2027
Figure 69: JapanMarket Attractiveness Analysis By Product Type, 2016 – 2026
Figure 70: Japan Market Attractiveness Analysis By End User, 2016 – 2026
Figure 71: MEA Market Share Analysis (%) By Country, 2017, 2027
Figure 72: MEA Market Y-o-Y Growth (%) By Country, 2017–2027
Figure 73: GCC Countries Market Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 74: South Africa Market Absolute $ Opportunity (US$ Mn) Forecast, 2017 – 2027
Figure 75: Rest of MEA Market Absolute $ Opportunity (US$ Mn) Forecast, 2017– 2027
Figure 76: MEA Market Attractiveness Analysis By End User, 2017 – 2027
Figure 77: MEA Market Attractiveness Analysis By Product Type, 2017 – 2027
Figure 78: MEA Market Attractiveness Analysis By Country, 2017 – 2027
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
